Skip to main content
. Author manuscript; available in PMC: 2013 Apr 26.
Published in final edited form as: Pharmacogenet Genomics. 2012 Nov;22(11):784–795. doi: 10.1097/FPC.0b013e3283589a76

Table 2.

The most common drugs implicated in drug-induced liver injury cases (drugs with n ≥ 5) in both the discovery sample and in the individuals available in the Drug-Induced Liver Injury Network replication cohort

N (%)
Drugs Discovery
sample
Replication
sample
Amoxicillin/clavulanate 208 (26.6) 42 (13.7)
Flucloxacillin 75 (9.6) 0 (0.0)
Diclofenac 30 (3.8) 4 (1.3)
Nitrofurantoin 24 (3.1) 15 (4.9)
Isoniazid 17 (2.2) 7 (2.3)
Sulfamethoxazole/trimethoprim 14 (1.8) 14 (4.6)
Valproic acid 13 (1.7) 2 (0.6)
Nimesulide 12 (1.5) 0 (0.0)
Minocycline 10 (1.3) 17 (5.5)
Celecoxib 8 (1.0) 1 (0.3)
Flucloxacillin and amoxicillin/
 clavulanate
8 (1.0) 0 (0.0)
Ciprofloxacin 7 (0.9) 9 (2.9)
Phenytoin 7 (0.9) 1 (0.3)
Azathioprine 6 (0.8) 5 (1.6)
Duloxetine 6 (0.8) 0 (0.0)
Telithromycin 6 (0.8) 0 (0.0)
Atorvastatin 5 (0.6) 3 (1.0)
Simvastatin 5 (0.6) 4 (1.3)
All other drugs and combinations 322 (41.1) 183 (59.6)